{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T09:07:13Z","timestamp":1781600833201,"version":"3.54.5"},"reference-count":21,"publisher":"BMJ","issue":"6368","license":[{"start":{"date-parts":[[1983,3,12]],"date-time":"1983-03-12T00:00:00Z","timestamp":416275200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br Med J (Clin Res Ed)"],"published-print":{"date-parts":[[1983,3,12]]},"abstract":"<jats:p>The blood pressure response to the first dose of captopril (6.25 mg, 12.5 mg, or 25 mg) was measured in 65 treated, severely hypertensive patients. Mean supine blood pressure was 187\/108 mm Hg immediately before captopril was given. Twenty one patients experienced a fall in supine systolic pressure greater than 50 mm Hg, including five whose pressure fell more than 100 mm Hg and two whose pressure fell more than 150 mm Hg. Six patients developed symptoms of acute hypotension, including dizziness, stupor, dysphasia, and hemiparesis. Percentage reductions in blood pressure were greatest in those with secondary hypertension (p less than 0.05), high pretreatment blood pressure (p less than 0.05), and high concentrations of plasma renin and angiotensin II (p less than 0.01). No significant correlation was found between fall in blood pressure and serum sodium concentration, age, renal function, and the dose of captopril given. A severe first dose effect cannot be consistently predicted in individual patients who have received other antihypertensive drugs for severe hypertension. Such patients should have close medical supervision for at least three hours after the first dose of captopril.<\/jats:p>","DOI":"10.1136\/bmj.286.6368.832","type":"journal-article","created":{"date-parts":[[2009,4,2]],"date-time":"2009-04-02T11:00:59Z","timestamp":1238670059000},"page":"832-834","source":"Crossref","is-referenced-by-count":97,"title":["Factors related to first dose hypotensive effect of captopril: prediction and treatment."],"prefix":"10.1136","volume":"286","author":[{"given":"G P","family":"Hodsman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C G","family":"Isles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G D","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T P","family":"Usherwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D J","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J I","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[1983,3,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/bmj.284.6317.689","article-title":"Captopril in renovascular hypertension: long-term use in predicting surgical outcome","volume":"284","author":"Atkinson, A.B.; Brown, J.J.; Cumming, A.M.M.","year":"1982","unstructured":"Atkinson AB, Brown JJ, Cumming AMM, et al. Captopril in renovascular hypertension: long-term use in predicting surgical outcome. Br Med J 1982;284:689-93.","journal-title":"Br Med J"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0033-0620(78)90025-7","article-title":"Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting enzyme inhibitor (SQ 14225, captopril) in hypertensive patients","volume":"21","author":"Case, D.B.; Atlas, S.A.; Laragh, J.H.; Sealey, J.E.; Sullivan, P.A.; McKinstry, D.N.","year":"1978","unstructured":"Case DB, Atlas SA, Laragh JH, Sealey JE, Sullivan PA, McKinstry DN. Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting enzyme inhibitor (SQ 14225, captopril) in hypertensive patients. Prog Cardiovasc Dis 1978;21:195-206.","journal-title":"Prog Cardiovasc Dis"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1440-1681.1980.tb00097.x","article-title":"Acute changes in blood pressure and vasoactive hormones after captopril in hypertensive patients","volume":"7","author":"McGrath, B.P.; Matthews, P.G.; Johnston, C.I.","year":"1980","unstructured":"McGrath BP, Matthews PG, Johnston CI. Acute changes in blood pressure and vasoactive hormones after captopril in hypertensive patients. Clin Exp Pharmacol Physiol 1980;7:487-91.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref_4","first-page":"50","article-title":"Benefits versus risks of captopril therapy","volume-title":"advances in hypertension therapy: captopril","author":"Atkinson, A.B.; Robertson, J.I.S.","year":"1981","unstructured":"Atkinson AB, Robertson JIS. Benefits versus risks of captopril therapy. In: Brunner HR, Gross F, eds. Recent advances in hypertension therapy: captopril. Amsterdam, Oxford, Princeton: Excerpta Medica, 1981: 50-63."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/0002-9149(82)90363-0","article-title":"Clinical experience with captopril in the treatment of severe drug-resistant hypertension","volume":"49","author":"Raine, A.E.G.; Ledingham, J.G.G.","year":"1982","unstructured":"Raine AEG, Ledingham JGG. Clinical experience with captopril in the treatment of severe drug-resistant hypertension. Am J Cardiol 1982; 49:1475-9.","journal-title":"Am J Cardiol"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1088\/0031-9155\/23\/3\/004","article-title":"Calibration and evaluation of a system for total body in vivo activation analysis using 14 MeV neutrons","volume":"23","author":"Williams, E.D.; Boddy, K.; Harvey, I.; Haywood, J.K.","year":"1978","unstructured":"Williams ED, Boddy K, Harvey I, Haywood JK. Calibration and evaluation of a system for total body in vivo activation analysis using 14 MeV neutrons. Phys Med Biol 1978;23:405-15.","journal-title":"Phys Med Biol"},{"key":"ref_7","first-page":"29","article-title":"Antagonists and inhibitors of the renin-angiotensin-aldosterone system in the treatment of hypertension","volume-title":"The therapeutics of hypertension","author":"Atkinson, A.B.; Brown, J.J.; Fraser, R.","year":"1980","unstructured":"Atkinson AB, Brown JJ, Fraser R, et al. Antagonists and inhibitors of the renin-angiotensin-aldosterone system in the treatment of hypertension. In: Robertson JIS, Pickering GW, eds. The therapeutics of hypertension. London: Royal Society of Medicine, 1980:29-61. (International Congress and Symposium Series No 26.)"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0009-8981(80)90050-9","article-title":"A microassay for active and total renin concentration in human plasma based on antibody trapping","volume":"101","author":"Millar, J.A.; Leckie, B.J.; Morton, J.J.; Jordan, J.; Tree, M.","year":"1980","unstructured":"Millar JA, Leckie BJ, Morton JJ, Jordan J, Tree M. A microassay for active and total renin concentration in human plasma based on antibody trapping. Clin Chim Acta 1980;101:5-15.","journal-title":"Clin Chim Acta"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2362.1971.tb00565.x","article-title":"Estimation of angiotensin II concentration in human plasma: some applications to physiological and clinical states","volume":"2","author":"Dusterdieck, G.; McElwee, G.","year":"1971","unstructured":"Dusterdieck G, McElwee G. Estimation of angiotensin II concentration in human plasma: some applications to physiological and clinical states. EurJ Clin Invest 1971;2:32-5.","journal-title":"EurJ Clin Invest"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1161\/01.HYP.2.4.586","article-title":"Captopril compared with other antirenin system agents in hypertensive patients: its triphasic effects on blood pressure and its use to identify and treat the renin factor","volume":"2","author":"Laragh, J.H.; Case, D.B.; Atlas, S.A.; Sealey, J.E.","year":"1980","unstructured":"Laragh JH, Case DB, Atlas SA, Sealey JE. Captopril compared with other antirenin system agents in hypertensive patients: its triphasic effects on blood pressure and its use to identify and treat the renin factor. Hypertension 1980;2:586-93.","journal-title":"Hypertension"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1042\/cs0580445","article-title":"The effect of captopril on blood pressure and angiotensins I, II and III in sodium depleted dogs: problems associated with the measurement of angiotensin II after inhihition of converting enzyme","volume":"58","author":"Morton, J.J.; Tree, M.; Casals-Stenzel, J.","year":"1980","unstructured":"Morton JJ, Tree M, Casals-Stenzel J. The effect of captopril on blood pressure and angiotensins I, II and III in sodium depleted dogs: problems associated with the measurement of angiotensin II after inhihition of converting enzyme. Clin Sci 1980;58:445-50.","journal-title":"Clin Sci"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1136\/hrt.44.3.290","article-title":"Captopril in clinical hypertension: changes in components of the renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition","volume":"44","author":"Atkinson, A.B.; Morton, J.J.; Brown, J.J.","year":"1980","unstructured":"Atkinson AB, Morton JJ, Brown JJ, et al. Captopril in clinical hypertension: changes in components of the renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition. Br Hearty 1980;44:290-6.","journal-title":"Br Hearty"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1536\/ihj.21.793","article-title":"Exaggerated response of renin secretion to captopril (SQ 14225) in renovascular hypertension","volume":"6","author":"Imai, Y.; Abe, K.; Otsuka, Y.","year":"1980","unstructured":"Imai Y, Abe K, Otsuka Y, et al. Exaggerated response of renin secretion to captopril (SQ 14225) in renovascular hypertension. J3pn Heart J 1980; 6:793-802.","journal-title":"J3pn Heart J"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1445-5994.1981.tb03512.x","article-title":"Use of captopril in the diagnosis of renal hypertension","volume":"11","author":"McGrath, B.P.; Matthews, P.G.; Johnston, C.I.","year":"1981","unstructured":"McGrath BP, Matthews PG, Johnston CI. Use of captopril in the diagnosis of renal hypertension. Aust NZJ Med 1981;11:359-63.","journal-title":"Aust NZJ Med"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1042\/cs0590451","article-title":"Evidence that the acute hypotensive effect of captopril in dogs is not wholly explained by a reduction of plasma angiotensin II and its direct vasoconstrictor effect","volume":"59","author":"Tree, M.; Morton, J.J.","year":"1980","unstructured":"Tree M, Morton JJ. Evidence that the acute hypotensive effect of captopril in dogs is not wholly explained by a reduction of plasma angiotensin II and its direct vasoconstrictor effect. Clin Sci 1980;59:451-6.","journal-title":"Clin Sci"},{"key":"ref_16","first-page":"144","article-title":"Plasma renin concentration in human hypertension. Relationship between renin, sodium and potassium","volume":"ii:","author":"Brown, J.J.; Davies, D.L.; Lever, A.F.; Robertson, J.I.S.","year":"1965","unstructured":"Brown JJ, Davies DL, Lever AF, Robertson JIS. Plasma renin concentration in human hypertension. Relationship between renin, sodium and potassium. Br Med J 1965;ii:144-8.","journal-title":"Br Med J"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0002-8703(70)90098-0","article-title":"Renin relationships in congestive heart failure, treated and untreated","volume":"80","author":"Brown, J.J.; Davies, D.L.; Johnson, N.W.; Lever, A.F.; Robertson, J.I.S.","year":"1970","unstructured":"Brown JJ, Davies DL, Johnson NW, Lever AF, Robertson JIS. Renin relationships in congestive heart failure, treated and untreated. Am Hearty 1970;80:329-42.","journal-title":"Am Hearty"},{"key":"ref_18","first-page":"161","article-title":"Hyponatraemia as a marker for high renin heart failure","volume-title":"Br Heart3","volume":"47","author":"Levine, T.B.; Franciosa, J.A.; Urobel, T.; Cohn, J.N.","year":"1982","unstructured":"Levine TB, Franciosa JA, Urobel T, Cohn JN. Hyponatraemia as a marker for high renin heart failure. Br Heart3 1982;47:161-6."},{"key":"ref_19","first-page":"105","article-title":"Hypertension and the cerebral circulation with special reference to the pathophysiology of central nervous system complications of treatment","volume-title":"The therapeutics of hypertension","author":"Graham, D.I.; Jones, J.V.","year":"1980","unstructured":"Graham DI, Jones JV. Hypertension and the cerebral circulation with special reference to the pathophysiology of central nervous system complications of treatment. In: Robertson JIS, Pickering GW, eds. The therapeutics of hypertension. London: Royal Society of Medicine, 1980:105-13. (International Congress and Symposium Series No 26.)"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/oxfordjournals.eurheartj.a061301","article-title":"Malignant hypertension and oral contraceptives: four cases, with two due to the 30, ug oestrogen pill","volume":"3","author":"Hodsman, G.P.; Robertson, J.I.S.; Semple, P.F.; Mackay, A.","year":"1982","unstructured":"Hodsman GP, Robertson JIS, Semple PF, Mackay A. Malignant hypertension and oral contraceptives: four cases, with two due to the 30,ug oestrogen pill. Eur HeartJ 1982;3:255-9.","journal-title":"Eur HeartJ"},{"key":"ref_21","article-title":"Accepted","year":"1982","unstructured":"(Accepted 30 December 1982)"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.286.6368.832","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.286.6368.832","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T20:41:26Z","timestamp":1765312886000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.286.6368.832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983,3,12]]},"references-count":21,"journal-issue":{"issue":"6368","published-online":{"date-parts":[[1983,3,12]]},"published-print":{"date-parts":[[1983,3,12]]}},"alternative-id":["10.1136\/bmj.286.6368.832"],"URL":"https:\/\/doi.org\/10.1136\/bmj.286.6368.832","relation":{},"ISSN":["0007-1447","1468-5833"],"issn-type":[{"value":"0007-1447","type":"print"},{"value":"1468-5833","type":"electronic"}],"subject":[],"published":{"date-parts":[[1983,3,12]]}}}